Data / Form D filings / ASLAN Pharmaceuticals Ltd
ASLAN Pharmaceuticals Ltd: Form D filings
ASLAN Pharmaceuticals Ltd, a biotechnology company in Singapore, Singapore, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on March 28, 2024, reports $5 million sold of a $5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 TEMASEK AVENUE, Level 18 Centennial Tower, Singapore, Singapore, 03919
- Phone
- (656) 817-9598
- Industry
- Biotechnology
- Entity type
- Other (ASLAN Pharmaceuticals Limited was incorporated in Cayman Islands on June 2014.)
- Incorporated in
- Cayman Islands
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1722926
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | New notice | $5,000,000 | $5,000,000 | 4 | Mar 14, 2024 | sec.gov | |
| Apr 26, 2023 | New notice | $100,000,000 | $20,000,000 | $80,000,000 | 7 | Feb 27, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexandre M. Kaoukhov | Executive Officer | |
| Carl Firth, Ph.D. | Executive Officer, Director | |
| Neil Graham, MBBS, M.D., MPH | Director | |
| Kathleen M. Metters | Director | |
| Ben M. Goodger | Executive Officer | |
| Stephen M. Doyle | Executive Officer | |
| Andrew Howden | Director | |
| Kiran Asarpota | Executive Officer | |
| Robert E. Hoffman | Director |
Every Form D from the week of Mar 25, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ASLAN Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.